Skip to content
Toggle Navigation
Registration & Hotel
Registration
Accommodation
Congress Venue
Invitation Letter
Program
On demand
Scientific Program
E-Posters
Timetable
Faculty
Industry Sessions
Adaptive Symposium
BMS Symposium
Gilead and Kite Symposium
GSK Symposium
J&J NDMM Symposium
J&J RRMM Symposium
PER® Symposium
Pfizer Symposium
Regeneron Symposium
Sanofi Symposium
Sebia Symposium
Springer Symposium
Information
Welcome Note
About COMy
The IACH
General Information
CME Accreditation
Italian Agent
Congress Partners
COMy Awards
2025 Impressions
Support
Supporters
Compliance
Contact
Contact
COMy 2026 Learners’ Questionnaire
COMy 2026 Learners’ Questionnaire
COMy 2026 Learners’ Questionnaire
COMy 2026 Learners’ Questionnaire
Adam Barkay
2026-04-15T06:47:43+02:00
Step
1
of
3
33%
Dear COMy Participant,
To receive your CME accreditation points for attending the 12th World Congress on Controversies in Multiple Myeloma (COMy), please complete the following learner’s questionnaire.
Many thanks,
The COMy Secretariatt
1. This event has fulfilled my educational goals and my expected learning outcomes
5 - Agree
4
3 - Neutral
2
1 - Disagree
2. I have learned information at this event that will help me to improve my practice
5 - Agree
4
3 - Neutral
2
1 - Disagree
3. The education provided at this event consistently was very good or excellent
5 - Agree
4
3 - Neutral
2
1 - Disagree
4. There was sufficient time for discussions, questions & answers and learner engagement
5 - Agree
4
3 - Neutral
2
1 - Disagree
5. The information presented was consistently supported by valid scientific evidence-based knowledge
5 - Agree
4
3 - Neutral
2
1 - Disagree
6. The speakers consistently were very good or excellent
5 - Agree
4
3 - Neutral
2
1 - Disagree
7. There was no bias in any of the programmed educational events
5 - Agree
4
3 - Neutral
2
1 - Disagree
Comments:
PROGRAM EVALUATION:
Required for reach session attended to provide a 3-5 sentence summary of content presented within the lectures and individual impression
Session 1: Advances in biology I
(Required)
Thursday, May 14 – 09:25-10:40
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 2: New response criteria
(Required)
Thursday, May 14 – 11:00-12:15
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 3: Mechanisms of resistance
(Required)
Thursday, May 14 – 15:15-16:30
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 4: Plenary lectures I
(Required)
Thursday, May 14 – 16:50-18:05
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 5: How I manage high risk disease
(Required)
Thursday, May 14 – 17:50-19:00
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 6: Webinar showcase from IACH I: Educating Patients for Better Outcomes
(Required)
Friday, May 15 – 07:00-08:00
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 7: Cure: hope, hype or reality? A Roundtable Discussion
(Required)
Friday, May 15 – 11:00-12:00
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 8: Webinar showcase from IACH II: Post-ASH 2025 Roundtable Debate
(Required)
Friday, May 15 – 13:30-13:45
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 9: COMy awards and lecture series
(Required)
Friday, May 15 – 13:50-14:25
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 10: IMS Session
(Required)
Friday, May 15 – 15:40-16:40
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 11: State-of-the-art management
(Required)
Friday, May 15 – 18:15-19:45
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 12: What’s new at aIACH: educational tools for your clinical day-to-day
(Required)
Friday, May 15 – 19:45-20:30
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 13: Clinical cases
(Required)
Saturday, May 16 – 07:00-08:00
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 14: The hard-to-treat patients
(Required)
Saturday, May 16 – 10:50-12:00
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 15: Webinar showcase from IACH III: Bispecific Antibodies in Multiple Myeloma: Practical Strategies for Safe and Effective Delivery
(Required)
Saturday, May 16 – 13:25-13:40
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 16: COMy debates
(Required)
Saturday, May 16 – 13:45-14:50
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Session 17: Plenary lectures II
(Required)
Saturday, May 16 – 17:30-19:30
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Multiple Myeloma Communications I
(Required)
Sunday, May 17 – 10:00-11:05
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Multiple Myeloma Communications II
(Required)
Sunday, May 17 – 11:15-12:20
Did you attend this session?
Yes
No
What was presented in this session and what is your key take-away?
(Required)
Summary in 3-5 sentences
Consent:
(Required)
I hereby confirm the completed form is correct and that I actively attended the 12th COMy Congress scientific sessions as marked herein
(Required)
Date
Signature
Title
(Required)
First Name
(Required)
Last Name
(Required)
Country of Origin
(Required)
Please select
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czechia
Côte d'Ivoire
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine, State of
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Romania
Russian Federation
Rwanda
Réunion
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Sweden
Switzerland
Syria Arab Republic
Taiwan
Tajikistan
Tanzania, the United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkmenistan
Turks and Caicos Islands
Tuvalu
Türkiye
US Minor Outlying Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Åland Islands
EBAH Member number
(Required)
Email Address
(Required)
Page load link
Go to Top